메뉴 건너뛰기




Volumn 155, Issue 3, 2013, Pages 429-437.e7

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 copernicus study

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; UNCLASSIFIED DRUG; VEGF TRAP EYE;

EID: 84873738185     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.09.026     Document Type: Article
Times cited : (301)

References (17)
  • 1
    • 0036946710 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion
    • J.B. Jonas, I. Kreissig, and R.F. Degenring Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 240 9 2002 782 783
    • (2002) Graefes Arch Clin Exp Ophthalmol , vol.240 , Issue.9 , pp. 782-783
    • Jonas, J.B.1    Kreissig, I.2    Degenring, R.F.3
  • 2
    • 79955552475 scopus 로고    scopus 로고
    • Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion
    • X. Ding, J. Li, X. Hu, S. Yu, J. Pan, and S. Tang Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion Retina 31 5 2011 838 845
    • (2011) Retina , vol.31 , Issue.5 , pp. 838-845
    • Ding, X.1    Li, J.2    Hu, X.3    Yu, S.4    Pan, J.5    Tang, S.6
  • 3
    • 79551548893 scopus 로고    scopus 로고
    • Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10
    • I.U. Scott, P.C. VanVeldhuisen, and N.L. Oden Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10 Ophthalmology 118 2 2011 345 352
    • (2011) Ophthalmology , vol.118 , Issue.2 , pp. 345-352
    • Scott, I.U.1    Vanveldhuisen, P.C.2    Oden, N.L.3
  • 4
    • 61349153538 scopus 로고    scopus 로고
    • SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion
    • I.U. Scott, P.C. VanVeldhuisen, and N.L. Oden SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion Ophthalmology 116 3 2009 504 512
    • (2009) Ophthalmology , vol.116 , Issue.3 , pp. 504-512
    • Scott, I.U.1    Vanveldhuisen, P.C.2    Oden, N.L.3
  • 5
    • 84862817252 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusions: Long-term follow-up in the HORIZON trial
    • J.S. Heier, P.A. Campochiaro, and L. Yau Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial Ophthalmology 119 4 2012 802 809
    • (2012) Ophthalmology , vol.119 , Issue.4 , pp. 802-809
    • Heier, J.S.1    Campochiaro, P.A.2    Yau, L.3
  • 6
    • 84862779327 scopus 로고    scopus 로고
    • Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: Six-month results of the Phase 3 COPERNICUS Study
    • D. Boyer, J. Heier, and D.M. Brown Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: six-month results of the Phase 3 COPERNICUS Study Ophthalmology 119 5 2012 1024 1032
    • (2012) Ophthalmology , vol.119 , Issue.5 , pp. 1024-1032
    • Boyer, D.1    Heier, J.2    Brown, D.M.3
  • 7
    • 77952889477 scopus 로고    scopus 로고
    • Ranibizumab for macular edema following central retinal vein occlusion: Six-month primary end point results of a phase III study
    • D.M. Brown, P.A. Campochiaro, and R.P. Singh Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 6 2010 1124 1133.e1121
    • (2010) Ophthalmology , vol.117 , Issue.6
    • Brown, D.M.1    Campochiaro, P.A.2    Singh, R.P.3
  • 8
    • 0037231664 scopus 로고    scopus 로고
    • Cytokine traps: Multi-component, high-Affinity blockers of cytokine action
    • A.N. Economides, L.R. Carpenter, and J.S. Rudge Cytokine traps: multi-component, high-Affinity blockers of cytokine action Nat Med 9 1 2003 47 52
    • (2003) Nat Med , vol.9 , Issue.1 , pp. 47-52
    • Economides, A.N.1    Carpenter, L.R.2    Rudge, J.S.3
  • 9
    • 0037143764 scopus 로고    scopus 로고
    • VEGF-Trap: A VEGF blocker with potent antitumor effects
    • J. Holash, S. Davis, and N. Papadopoulos VEGF-Trap: a VEGF blocker with potent antitumor effects Proc Natl Acad Sci U S A 99 17 2002 11393 11398
    • (2002) Proc Natl Acad Sci U S A , vol.99 , Issue.17 , pp. 11393-11398
    • Holash, J.1    Davis, S.2    Papadopoulos, N.3
  • 10
    • 84865129521 scopus 로고    scopus 로고
    • Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    • N. Papadopoulos, J. Martin, and Q. Ruan Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab Angiogenesis 15 2 2012 171 185
    • (2012) Angiogenesis , vol.15 , Issue.2 , pp. 171-185
    • Papadopoulos, N.1    Martin, J.2    Ruan, Q.3
  • 11
    • 43649083100 scopus 로고    scopus 로고
    • Predicted biological activity of intravitreal VEGF Trap
    • M.W. Stewart, and P.J. Rosenfeld Predicted biological activity of intravitreal VEGF Trap Br J Ophthalmol 92 5 2008 667 668
    • (2008) Br J Ophthalmol , vol.92 , Issue.5 , pp. 667-668
    • Stewart, M.W.1    Rosenfeld, P.J.2
  • 12
    • 0022347471 scopus 로고
    • Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group
    • Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group Arch Ophthalmol 103 12 1985 1796 1806
    • (1985) Arch Ophthalmol , vol.103 , Issue.12 , pp. 1796-1806
  • 13
    • 0028802677 scopus 로고
    • Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report
    • Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report Ophthalmology 102 10 1995 1425 1433
    • (1995) Ophthalmology , vol.102 , Issue.10 , pp. 1425-1433
  • 14
    • 41149085598 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator
    • P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 4 2008 791 799
    • (2008) Mol Ther , vol.16 , Issue.4 , pp. 791-799
    • Campochiaro, P.A.1    Hafiz, G.2    Shah, S.M.3
  • 15
    • 84864444516 scopus 로고    scopus 로고
    • One-year outcomes of the da VINCI study of VEGF trap-eye in eyes with diabetic macular edema
    • D.V. Do, Q.D. Nguyen, and D. Boyer One-year outcomes of the DA VINCI study of VEGF trap-eye in eyes with diabetic macular edema Ophthalmology 119 8 2012 1658 1665
    • (2012) Ophthalmology , vol.119 , Issue.8 , pp. 1658-1665
    • Do, D.V.1    Nguyen, Q.D.2    Boyer, D.3
  • 16
    • 79958843614 scopus 로고    scopus 로고
    • Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: Twelve-month outcomes of a phase III study
    • P.A. Campochiaro, D.M. Brown, and C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 10 2011 2041 2049
    • (2011) Ophthalmology , vol.118 , Issue.10 , pp. 2041-2049
    • Campochiaro, P.A.1    Brown, D.M.2    Awh, C.C.3
  • 17
    • 84863320414 scopus 로고    scopus 로고
    • Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results
    • D.F. Martin, M.G. Maguire, and S.L. Fine Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398
    • (2012) Ophthalmology , vol.119 , Issue.7 , pp. 1388-1398
    • Martin, D.F.1    Maguire, M.G.2    Fine, S.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.